Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,944 | 61,741 | 207,555 | 192,151 | 206,154 |
| Marketable Securities | 112,949 | 151,683 | N/A | N/A | N/A |
| Receivables | 54,823 | 46,158 | 27,619 | 29,983 | 35,901 |
| Inventories | 55,724 | 56,760 | 42,326 | 27,310 | 21,157 |
| TOTAL | $278,440 | $316,342 | $277,500 | $249,444 | $263,212 |
| Non-Current Assets | |||||
| PPE Net | 7,752 | 9,689 | 10,392 | 13,222 | 12,226 |
| Investments And Advances | 4,233 | 10,398 | 9,731 | 8,650 | 7,118 |
| Intangibles | 61,039 | 71,267 | 75,121 | 83,834 | 94,083 |
| Other Non-Current Assets | 48,521 | 55,158 | 53,053 | 42,165 | 41,814 |
| TOTAL | $121,545 | $146,512 | $148,297 | $147,871 | $155,241 |
| Total Assets | $399,985 | $462,854 | $425,797 | $397,315 | $418,453 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,245 | 1,824 | 1,768 | 1,879 | 2,040 |
| Accounts payable and accrued liabilities | 66,611 | 72,528 | 54,465 | 42,473 | 47,666 |
| Other current liabilities | N/A | N/A | N/A | N/A | 25,181 |
| TOTAL | $73,802 | $77,968 | $59,698 | $46,771 | $76,849 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 105,122 | 166,105 | 161,461 | 157,628 | 158,169 |
| TOTAL | $105,122 | $166,105 | $161,461 | $157,628 | $158,169 |
| Total Liabilities | $178,924 | $244,073 | $221,159 | $204,399 | $235,018 |
| Shareholders' Equity | |||||
| Common Shares | 7,769 | 7,669 | 7,509 | 7,429 | 7,312 |
| Retained earnings | -275,489 | -265,262 | -256,431 | -273,167 | -295,621 |
| Other shareholders' equity | -209 | -2,057 | -8,737 | 3,400 | 24,614 |
| TOTAL | $221,061 | $218,781 | $204,638 | $192,916 | $183,435 |
| Total Liabilities And Equity | $399,985 | $462,854 | $425,797 | $397,315 | $418,453 |